OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PRME

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Prime Medicine (PRME) Earnings Date & Reports

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PRME is expected to report earnings to rise 4.88% to -43 cents per share on October 31

Prime Medicine PRME Stock Earnings Reports

Q3'25

Est.

$-0.43

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.18

Q3'24

Beat

by $0.05

The last earnings report on August 07 showed earnings per share of -40 cents, beating the estimate of -43 cents. With 934.16K shares outstanding, the current market capitalization sits at 674.77M.

View a ticker or compare two or three

Compare

PRME

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PRME
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRME showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

21 Erie Street

Phone

+1 617 564-0013

Employees

234

Web

https://www.primemedicine.com